Hyloris Pharmaceuticals SAEURONEXT: HYL

Hyloris Pharmaceuticals Announces Positive Clinical Study Results for IV Aspirin

· Issued by Hyloris Pharmaceuticals SA

14 Nov 2025 07:38 CET

Subscribe
Issuer

HYLORIS PHARMACEUTICALS SA

pr-aspirin-iv-positive-clinical-trial-results.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext

Hyloris Pharmaceuticals SA on 6ix

Earlier from Hyloris Pharmaceuticals

Later from Hyloris Pharmaceuticals

All Hyloris Pharmaceuticals news releases